The tumorigenic potential of PDX has been shown to be conferred by a relatively small population of CRC cells that are marked by stem cell markers for normal intestinal epithelium, such as CD133, CD44, or LGR5 (leucine-rich repeat-containing G-coupled receptor 5) (7, 8, 14–16). This evidence concerns the gene PROM1 and colorectal carcinoma.